AzTrials
AzTrials

Cardiac Arrest (CA)Lazarus-AOINCT07438938

Measurement of Airway Opening Index During Out-of-hospital Cardiac Arrest: The Lazarus AOI Trial.

An observational study of Cardiac Arrest (CA) and Out-of-hospital Cardiac Arrest (OHCA), run by University Hospital, Ghent at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Out-of-hospital cardiac arrest (OHCA) is a leading cause of death worldwide. Despite constantly improving resuscitation techniques, the chances of survival remain limited. During cardiopulmonary resuscitation (CPR), a closure of the airway may occur, impeding ventilation. Read more about this study

Who is it for?
Ages 18 years and older
How many people
150 participants
Where
1 siteBelgium
Study dates
1 Oct 2022to 1 Jan 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: This retrospective observational cohort study included adult patients who suffered an out-of-hospital cardiac arrest (OHCA) and were treated by the Mobile Emergency Team (MET) of Ghent University Hospital. All cases were registered in the Lazarus database, which prospectively collects prehospital CPR data including continuous capnography recordings.

Who may be able to join

  • Adult (over 18 years old) patients with out-of-hospital cardiac arrest.
  • Patients undergoing cardiopulmonary resuscitation (CPR).
  • Patients who were intubated and had available capnogram recordings immediately after intubation.

Who cannot join

  • Patients that were not intubated
  • Patients that did not receive CPR following intubation
  • Cases with a technical challenge with the ETCO₂ measurement (i.e., issues with waveform data of the capnogram.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Said Hachimi Idrissi, MD, PhD contact

0032 9 332 50 24

SAID.HACHIMIIDRISSI@ugent.be

Thomas Tackaert, MD contact

thomas.tackaert@ugent.be

Belgium1 site, 1 recruiting
  • Ghent University Hospital

    Ghent, East-Flanders, B9000

    Said Hachimi Idrissi, MD, PhD, 0032 9 332 50 24, SAID.HACHIMIIDRISSI@ugent.be

    Recruiting

Other trials in Belgium

About this study

Out-of-hospital cardiac arrest (OHCA) is a leading cause of death worldwide. Despite constantly improving resuscitation techniques, the chances of survival remain limited. During cardiopulmonary resuscitation (CPR), a closure of the airway may occur, impeding ventilation. This phenomenon also complicates the interpretation of the end-tidal CO2 (ETCO2) in the capnogram. The extent to which airway closure occurs is quantified by the Airway Opening Index (AOI). This can be calculated from the capnogram and is seen as a measure of the quality of CPR applied as well as a possible indicator to predict the outcome of CPR.

In this study, we analyse capnogram data from approximately 150 cases, collected during interventions for OHCA and logged in the Lazarus database (UZ Gent and AZORG) to answer three research questions below:

Read more
  1. What is the prevalence of AOI during CPR?
  2. Is there a correlation between AOI and return of spontaneous circulation (ROSC)?
  3. Does the application of positive end-expiratory pressure (PEEP) affect the AOI and ROSC?

A mathematical model for calculating AOI, based on a method from previous work by Bandhari et al. [1] will be developed. Using this model, the AOI will be calculated from the individual capnograms for all cases in the Lazarus database.

In addition, a multivariable regression model will be used to analyse whether AOI can be used to predict ROSC. Corrections will be made for relevant confounders such as age, gender, witnessed arrest and rhythm pattern.

Finally, it is investigated whether PEEP has a positive influence on AOI. This study aims to contribute to better insights into airway dynamics during CPR and the optimization of ventilation in OHCA.

Read the detailed description

This study is a retrospective observational cohort study based on capnography data from out-of-hospital cardiac arrest cases registered in the Lazarus database.

Keywords
capnography, airway closure
Medical subject headings
Heart Arrest, Out-of-Hospital Cardiac Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07438938
Study groupRoleWhat they receive
ROSCPatients with return-of-spontaneous circulation during initial resuscitation.
non-ROSCPatients without return-of-spontaneous circulation during initial resuscitation.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ROSC

    Return-of-spontaneous circulation during initial resuscitation.

    Measured: Initial resuscitation (first day)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2026
  2. Study start1 Oct 2022
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion1 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07438938
Sponsor's protocol ID
ONZ-2025-0418
Acronym
Lazarus-AOI
Status last verified
Nov 2025
First submitted
14 Nov 2025
Last updated
27 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Arrest (CA) and Out-of-hospital Cardiac Arrest (OHCA), run by University Hospital, Ghent at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Said Hachimi Idrissi, MD, PhD (0032 9 332 50 24, SAID.HACHIMIIDRISSI@ugent.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ROSC (time frame: Initial resuscitation (first day)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in